{"id":"W4410038451","doi":"10.1016/j.euo.2025.04.004","title":"Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the JAVELIN Bladder 100 Trial","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck; Pfizer; Merck Healthcare KGaA","keywords":"Medicine; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Avelumab; Javelin; Oncology; Toxicity; Internal medicine; Urology; Bladder cancer; Immunotherapy; Cancer; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005173394,0.0004057667,0.001335327,0.0001452454,0.0001902808,0.00001249564,0.0002624812,0.0002159551,0.0002587123],"category_scores_gemma":[0.001198776,0.0002489596,0.0002695687,0.0002274034,0.0005709808,0.00005316204,0.0001854759,0.0003168422,0.00001939989],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001192989,"about_ca_system_score_gemma":0.0004911564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002846208,"about_ca_topic_score_gemma":0.0005149625,"domain_scores_codex":[0.9964854,0.0008905428,0.001208697,0.0007434458,0.0001978689,0.0004740269],"domain_scores_gemma":[0.996725,0.00155575,0.0006194406,0.0006984384,0.0002705405,0.0001308507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3752722,0.003350193,0.5475481,0.0001663157,0.006121004,0.00059151,0.001862754,0.00005010859,0.008093419,0.000145249,0.001746393,0.05505282],"study_design_scores_gemma":[0.193699,0.01430458,0.7801109,0.0000659869,0.003466912,0.00008008222,0.0001091048,0.0001399615,0.002541747,0.0001200673,0.005000776,0.000360892],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894639,0.0005996622,0.001047894,0.003517209,0.0007296471,0.002512754,0.0002419877,0.00008242296,0.001804566],"genre_scores_gemma":[0.9909889,0.00008320755,0.0005461734,0.004862261,0.0002613715,0.0001422645,0.0001448845,0.00005719887,0.002913771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2325628,"threshold_uncertainty_score":0.9999962,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06087568181395224,"score_gpt":0.3749091265974353,"score_spread":0.3140334447834831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}